BROWSE TOPICS

RESOURCES

ABOUT THIS SITE

 

Riverain gets FDA approval of lung cancer-detection software

Riverain Technologies has received regulatory approval for the next-generation version of its imaging software that suppresses bones to help radiologists detect cancerous lung nodules. Advertisement The new version of the software offers greater sensitivity, meaning it can better detect nodules, and better specificity, meaning it yields fewer false positives, said Steve Worrell, Riverains chief technology officer. A recent study of the new version of OnGuard by researchers at University of Chicago Medical Center found that the software identified 25 percent more lung cancers than radiologists found when reviewing the same X-rays without OnGuard. Brandon Glenn MedCity News Brandon Glenn is the Ohio bureau chief for MedCity News.

Author: Publication Date: Crawl Date: Source: Topic: Contributor: Type: Language: Format:
December 01, 2011 December 04, 2011 MedCity News via Google News Applications MachineLearning Vision NewsFinder Text English HTML

Whitelist words:

  1. machin learn: 1 occurrence
  2. pattern recognit: 1 occurrence

Categorization (need >= 0.5 to match):

  1. AIOverview: 0.0117594
  2. Agents: 0.00306497
  3. Applications: 0.972313
  4. CognitiveScience: 0.0378371
  5. Education: 0.0154354
  6. Ethics: 0.0733731
  7. Games: 0.00268814
  8. History: 0.00585753
  9. Interfaces: 0.0259496
  10. MachineLearning: 0.668698
  11. NaturalLanguage: 0.0383098
  12. Philosophy: 0.0235546
  13. Reasoning: 0.00656204
  14. Representation: 0.0163754
  15. Robots: 0.0466323
  16. ScienceFiction: 0.00172544
  17. Speech: 0.0245109
  18. Systems: 0.0150032
  19. Vision: 0.749242

Duplicates (threshold=0.17):

Transcript:

  1. Published
Collections:
brokenlinkform:brokenlink
AAAI   Recent Changes   Edit   History   Print   Contact Us
Page last modified on December 05, 2011, at 12:00 AM